SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001123292-16-001517
Filing Date
2016-01-06
Accepted
2016-01-06 19:04:54
Documents
1
Period of Report
2016-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3821
  Complete submission text file 0001123292-16-001517.txt   5291
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
BALTIMORE DAVID (Reporting) CIK: 0001185858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36561 | Film No.: 161328385

Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Issuer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations